Publications Authored by Neal D Shore

Download full-text PDF	Source
http://ascopubs.org/doi/10.1200/JCO.18.02031	Publisher Site
http://dx.doi.org/10.1200/JCO.18.02031	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494360	PMC

May 2019

Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review.

Authors:

Stephen B Williams Mohamed D Ray-Zack Hogan K Hudgins Jan Oldenburg Quoc-Dien Trinh Paul L Nguyen Neal D Shore Manfred P Wirth Timothy O'Brien James W F Catto

Eur Urol Oncol 2019 May 5;2(3):265-273. Epub 2018 Nov 5.

Academic Urology Unit, University of Sheffield, Sheffield, UK.

View Article

Download full-text PDF	Source
https://linkinghub.elsevier.com/retrieve/pii/S25889311183018	Publisher Site
http://dx.doi.org/10.1016/j.euo.2018.10.006	DOI Listing

May 2019

A New Sustained-release, 3-Month Leuprolide Acetate Formulation Achieves and Maintains Castrate Concentrations of Testosterone in Patients With Prostate Cancer.

Authors:

Neal D Shore Sílvia Guerrero Rosa Ma Sanahuja Gemma Gambús Antonio Parente

Clin Ther 2019 03 8;41(3):412-425. Epub 2019 Feb 8.

GP-Pharm S.A., Pol. Industrial Els Vinyets-Els Fogars, St. Quintí de Mediona, Barcelona, Spain.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.clinthera.2019.01.004	DOI Listing

March 2019

The Effect of Local Antibiogram-based Augmented Antibiotic Prophylaxis on Infection-related Complications Following Prostate Biopsy.

Authors:

Raoul S Concepcion Edward M Schaeffer Neal D Shore Deepak A Kapoor Jeffrey A Scott Gary M Kirsh

Rev Urol 2019 ;21(2-3):93-101

The Urology Group Cincinnati, OH.

View Article

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864918	PMC

January 2019

Preserving Independent Urology: LUGPA's First Decade.

Authors:

Neal D Shore Deepak A Kapoor Evan R Goldfischer David C Chaikin Earl L Walz R Jonathan Henderson Richard G Harris Robert D Asinof Gary M Kirsh

Rev Urol 2019 ;21(2-3):102-108

Past President and Current Chair, Political Affairs Committee and Advanced Payment Model Task Force, LUGPA; The Urology Group Cincinnati, OH.

View Article

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864914	PMC

January 2019

Phase I Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer.

Authors:

Shilpa Gupta Luke T Nordquist Mark T Fleming William R Berry Jingsong Zhang Sharon L Ervin Joel R Eisner Edwina S Baskin-Bey Neal D Shore

Clin Cancer Res 2018 11 16;24(21):5225-5232. Epub 2018 Jul 16.

Carolina Urologic Research Center, Myrtle Beach, South Carolina.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0564	DOI Listing

November 2018

Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.

Authors:

Neil M Schultz Neal D Shore Simon Chowdhury Laurence H Klotz Raoul S Concepcion David F Penson Lawrence I Karsh Hongbo Yang Bruce A Brown Arie Barlev Scott C Flanders

BMC Urol 2018 10 1;18(1):84. Epub 2018 Oct 1.

Astellas Pharma, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1186/s12894-018-0397-5	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166278	PMC

October 2018

Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.

Authors:

Neil M Schultz Neal D Shore Simon Chowdhury Laurence H Klotz Raoul S Concepcion David F Penson Lawrence I Karsh Hongbo Yang Bruce A Brown Arie Barlev Scott C Flanders

BMC Urol 2018 Sep 6;18(1):77. Epub 2018 Sep 6.

Astellas Pharma, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1186/s12894-018-0387-7	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128000	PMC

September 2018

The IMAAGEN Study: Effect of Abiraterone Acetate and Prednisone on Prostate Specific Antigen and Radiographic Disease Progression in Patients with Nonmetastatic Castration Resistant Prostate Cancer.

Authors:

Charles J Ryan E David Crawford Neal D Shore Willie Underwood Mary-Ellen Taplin Anil Londhe Peter St John Francis Jennifer Phillips Tracy McGowan Philip W Kantoff

J Urol 2018 08 6;200(2):344-352. Epub 2018 Apr 6.

Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.juro.2018.03.125	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429921	PMC

August 2018

Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR Trials.

Authors:

Neal D Shore Teuvo L Tammela Christophe Massard Petri Bono John Aspegren Mika Mustonen Karim Fizazi

Eur Urol Focus 2018 07 14;4(4):547-553. Epub 2017 Feb 14.

Institut Gustave Roussy, University of Paris Sud, Villejuif, France.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.euf.2017.01.015	DOI Listing

July 2018

Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data.

Authors:

Lawrence I Karsh Eric T Gross Christopher M Pieczonka Philip J Aliotta Christopher J Skomra Lee E Ponsky Peter T Nieh Misop Han Daniel A Hamstra Neal D Shore

Urology 2018 May 23;115:39-44. Epub 2017 Nov 23.

Carolina Urologic Research Center, Myrtle Beach, SC. Electronic address:

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.urology.2017.11.016	DOI Listing

May 2018

Recognizing Symptom Burden in Advanced Prostate Cancer: A Global Patient and Caregiver Survey.

Authors:

Lawrence Drudge-Coates William K Oh Bertrand Tombal Anthony Delacruz Brian Tomlinson Aimee Vella Ripley Ken Mastris Joe M O'Sullivan Neal D Shore

Clin Genitourin Cancer 2018 04 5;16(2):e411-e419. Epub 2017 Oct 5.

Carolina Urologic Research Center, Myrtle Beach, SC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.clgc.2017.09.015	DOI Listing

April 2018

eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate Cancer.

Authors:

Neal D Shore Ronald F Tutrone Neil F Mariados Luke T Nordquist Bryan A Mehlhaff Karyn J Steere Stacey S Harrelson

Clin Genitourin Cancer 2018 04 7;16(2):149-154. Epub 2017 Nov 7.

Carolina Urologic Research Center, Myrtle Beach, SC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.clgc.2017.10.022	DOI Listing

April 2018

Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker.

Authors:

Rachel A Levin Maria E Lund Quach Truong Angela Wu Neal D Shore Daniel R Saltzstein Raoul S Concepcion Thomas A Paivanas Arletta van Breda Jennifer Beebe-Dimmer Julie J Ruterbusch Sandra Wissmueller Douglas H Campbell Bradley J Walsh

Oncotarget 2018 Apr 27;9(32):22359-22367. Epub 2018 Apr 27.

Minomic International Ltd, Sydney, New South Wales, Australia.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.18632/oncotarget.25009	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976470	PMC

April 2018

Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET.

Authors:

Scott C Flanders Janet Kim Samuel Wilson Jeffrey Braziunas Sheldon Greenfield John Billimek Stanislav Lechpammer Daniel W Lin Lawrence Karsh David I Quinn Daniel Shevrin Neal D Shore James T Symanowski David F Penson

Future Oncol 2018 Mar 8;14(6):527-536. Epub 2018 Feb 8.

Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN 37250, USA.

View Article

Download full-text PDF	Source
https://www.futuremedicine.com/doi/10.2217/fon-2017-0438	Publisher Site
http://dx.doi.org/10.2217/fon-2017-0438	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941708	PMC

March 2018

Optimizing the treatment of metastatic castration-resistant prostate cancer: a Latin America perspective.

Authors:

Juan Pablo Sade Carlos Alberto Vargas Báez Martin Greco Carlos Humberto Martínez Miguel Ángel Álvarez Avitia Carlos Palazzo Narciso Hernández Toriz Patricia Isabel Bernal Trujillo Diogo Assed Bastos Fabio Augusto Schutz Santiago Bella Lucas Nogueira Neal D Shore

Med Oncol 2018 Mar 19;35(4):56. Epub 2018 Mar 19.

Department of Urology, Carolina Urologic Research Center, 823 82nd Parkway, Myrtle Beach, SC, 29572, USA.

View Article

Download full-text PDF	Source
http://link.springer.com/10.1007/s12032-018-1105-8	Publisher Site
http://dx.doi.org/10.1007/s12032-018-1105-8	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859699	PMC

March 2018

Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program.

Authors:

Oliver Sartor Nicholas J Vogelzang Christopher Sweeney Daniel C Fernandez Fabio Almeida Andrei Iagaru Alan Brown Matthew R Smith Manish Agrawal Adam P Dicker Jorge A Garcia Jose Lutzky Yu-Ning Wong Oana Petrenciuc Jeremy Gratt Neal D Shore Michael J Morris

Oncologist 2018 02 28;23(2):193-202. Epub 2017 Nov 28.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF	Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th	Publisher Site
http://dx.doi.org/10.1634/theoncologist.2017-0413	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813754	PMC

February 2018

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

Authors:

Veda N Giri Karen E Knudsen William K Kelly Wassim Abida Gerald L Andriole Chris H Bangma Justin E Bekelman Mitchell C Benson Amie Blanco Arthur Burnett William J Catalona Kathleen A Cooney Matthew Cooperberg David E Crawford Robert B Den Adam P Dicker Scott Eggener Neil Fleshner Matthew L Freedman Freddie C Hamdy Jean Hoffman-Censits Mark D Hurwitz Colette Hyatt William B Isaacs Christopher J Kane Philip Kantoff R Jeffrey Karnes Lawrence I Karsh Eric A Klein Daniel W Lin Kevin R Loughlin Grace Lu-Yao S Bruce Malkowicz Mark J Mann James R Mark Peter A McCue Martin M Miner Todd Morgan Judd W Moul Ronald E Myers Sarah M Nielsen Elias Obeid Christian P Pavlovich Stephen C Peiper David F Penson Daniel Petrylak Curtis A Pettaway Robert Pilarski Peter A Pinto Wendy Poage Ganesh V Raj Timothy R Rebbeck Mark E Robson Matt T Rosenberg Howard Sandler Oliver Sartor Edward Schaeffer Gordon F Schwartz Mark S Shahin Neal D Shore Brian Shuch Howard R Soule Scott A Tomlins Edouard J Trabulsi Robert Uzzo Donald J Vander Griend Patrick C Walsh Carol J Weil Richard Wender Leonard G Gomella

J Clin Oncol 2018 02 13;36(4):414-424. Epub 2017 Dec 13.

Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center; Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine; S. Bruce Malkowicz, University of Pennsylvania; Elias Obeid and Robert Uzzo, Fox Chase Cancer Center; Gordon F. Schwartz, Foundation for Breast and Prostate Health, Philadelphia; Mark S. Shahin, Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Abington, PA; Wassim Abida, Philip Kantoff, and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mitchell C. Benson, Columbia University, New York, NY; Gerald L. Andriole, Washington University School of Medicine, St Louis, MO; Chris H. Bangma, Erasmus Medical Center, Rotterdam, the Netherlands; Amie Blanco, and Matthew Cooperberg, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco; Christopher J. Kane, University of California San Diego, San Diego; Howard Sandler, Cedars-Sinai Medical Center, Los Angeles; Howard R. Soule, Prostate Cancer Foundation, Santa Monica, CA; Arthur Burnett, William B. Isaacs, Christian P. Pavlovich, and Patrick C. Walsh, Johns Hopkins Medical Institutions, Baltimore; Peter A. Pinto and Carol J. Weil, National Cancer Institute, Bethesda, MD; William J. Catalona and Edward Schaeffer, Northwestern University Feinberg School of Medicine; Scott Eggener, Sarah M. Nielsen, and Donald J. Vander Griend, University of Chicago, Chicago, IL; Kathleen A. Cooney, University of Utah School of Medicine, Salt Lake City, UT; David E. Crawford, University of Colorado, Aurora; Lawrence I. Karsh, The Urology Center of Colorado, Denver; Wendy Poage, Prostate Conditions Education Council, Elizabeth, CO; Neil Fleshner, University of Toronto Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Matthew L. Freedman, Kevin R. Loughlin, and Timothy R. Rebbeck, Dana Farber Cancer Institute, and Harvard TH Chan School of Public Health, Boston, MA; Freddie C. Hamdy, University of Oxford, Oxford, England; R. Jeffrey Karnes, Mayo Clinic, Rochester, MN; Eric A. Klein, Cleveland Clinic, Cleveland; Robert Pilarski, The Ohio State University, Columbus, OH; Daniel W. Lin, University of Washington, Seattle, WA; Martin M. Miner, Brown University, Providence, RI; Todd Morgan and Scott A. Tomlins, University of Michigan, Ann Arbor; Matt T. Rosenberg, Mid-Michigan Health Center, Jackson, MI; Judd W. Moul, Duke University, Duke Cancer Institute, Durham, NC; David F. Penson, Vanderbilt University Medical Center, Nashville, TN; Daniel Petrylak and Brian Shuch, Yale University, New Haven, CT; Curtis A. Pettaway, The University of Texas MD Anderson Cancer Center, Houston; Ganesh V. Raj, University of Texas Southwestern Medical Center at Dallas, Dallas, TX; Oliver Sartor, Tulane University Medical School, New Orleans, LA; Neal D. Shore, Atlantic Urology Clinics/Carolina Urologic Research Center, Myrtle Beach, SC; and Richard Wender, American Cancer Society, Atlanta, GA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1200/JCO.2017.74.1173	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075860	PMC

February 2018

Pharmacokinetic and pharmacodynamic comparison of subcutaneous intramuscular leuprolide acetate formulations in male subjects.

Authors:

Daniel Saltzstein Neal D Shore Judd W Moul Franklin Chu Raoul Concepcion Stephan de la Motte John A McLane Stuart Atkinson Alex Yang E David Crawford

Ther Adv Urol 2018 Feb 22;10(2):43-50. Epub 2017 Nov 22.

University of Colorado at Denver, CO, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1177/1756287217738150	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805007	PMC

February 2018

Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration Resistant Prostate Cancer in the TERRAIN Trial.

Authors:

D Robert Siemens Laurence Klotz Axel Heidenreich Simon Chowdhury Arnauld Villers Benoit Baron Steve van Os Nahla Hasabou Fong Wang Ping Lin Neal D Shore

J Urol 2018 01 19;199(1):147-154. Epub 2017 Aug 19.

Carolina Urologic Research Center, Myrtle Beach, South Carolina, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.juro.2017.08.080	DOI Listing

January 2018

LUGPA Onsite and LUGPA Virtual Crossfire Programs Offer Novel Alternatives to Attending an Out-oftown LUGPA Meeting.

Authors:

Neal D Shore

Rev Urol 2018 ;20(1):26-27

President, LUGPA; Atlantic Urology Clinics Myrtle Beach, SC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3909/riu0791	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003300	PMC

January 2018

Member Census Shows LUGPA Practices Exhibit High Level of Innovation, Sophistication, and Growth.

Authors:

Scott B Sellinger Neal D Shore

Rev Urol 2018 ;20(2):94-97

Atlantic Urology Clinics Myrtle Beach, SC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3909/riu0805	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168330	PMC

January 2018

LUGPA Celebrates Its 10th Anniversary at Its 2018 Annual Meeting.

Authors:

Neal D Shore

Rev Urol 2018 ;20(3):131-132

Atlantic Urology Clinics Myrtle Beach, SC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3909/riu0816	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241896	PMC

January 2018

Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.

J Clin Oncol 2017 Oct 23;35(30):3410-3416. Epub 2017 Aug 23.

Neal D. Shore, Carolina Urologic Research Center, Myrtle Beach, SC; Stephen A. Boorjian, Mayo Clinic, Rochester, MN; Daniel J. Canter, Ochsner Health System, New Orleans, LA; Kenneth Ogan, Emory University, Atlanta, GA; Lawrence I. Karsh, The Urology Center of Colorado, Denver, CO; Tracy M. Downs, University of Wisconsin, Madison, WI; Leonard G. Gomella, Thomas Jefferson University, Philadelphia, PA; Ashish M. Kamat and Colin P.N. Dinney, University of Texas MD Anderson Cancer Center; Seth P. Lerner, Baylor College of Medicine, Houston; Yair Lotan, University of Texas Southwestern Medical Center, Dallas; Robert S. Svatek, University of Texas Health Science Center at San Antonio, San Antonio, TX; Trinity J. Bivalacqua, Johns Hopkins School of Medicine, Baltimore, MD; Robert L. Grubb III, Washington University, St Louis, MO; Tracey L. Krupski, University of Virginia, Charlottesville, VA; Michael E. Woods and Matthew I. Milowsky, University of North Carolina, Chapel Hill; Brant A. Inman, Duke University, Durham, NC; Alan Boyd, Alan Boyd Consultants, Cottenham; F. Peter Treasure, Peter Treasure Statistical Services, King's Lynn, United Kingdom; Gillian Gregory, David G. Sawutz, and Nigel R. Parker, FKD Therapies Oy; and Seppo Yla-Herttuala, A.I. Virtanen Institute University of Eastern Finland and Science Service Center and Gene Therapy Unit, Kuopio, Finland.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1200/JCO.2017.72.3064	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648171	PMC

October 2017

Impact of subsequent metastases on costs and medical resource use for prostate cancer patients initially diagnosed with localized disease.

Authors:

Tracy T Li Neal D Shore Maneesha Mehra Mary B Todd Ryan Saadi Gaetan Leblay Jyoti Aggarwal Robert I Griffiths

Cancer 2017 Sep 23;123(18):3591-3601. Epub 2017 May 23.

Boston Health Economics, Waltham, Massachusetts.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1002/cncr.30784	DOI Listing

September 2017

Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone.

Authors:

Dana E Rathkopf Emmanuel S Antonarakis Neal D Shore Ronald F Tutrone Joshi J Alumkal Charles J Ryan Mansoor Saleh Ralph J Hauke Rajesh Bandekar Edna Chow Maneval Carla J de Boer Margaret K Yu Howard I Scher

Clin Cancer Res 2017 Jul 17;23(14):3544-3551. Epub 2017 Feb 17.

Sidney Kimmel Center for Prostate and Urologic Cancers, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2509	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543693	PMC

July 2017

Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.

Authors:

Matthew R Smith Fred Saad Dana E Rathkopf Peter F A Mulders Johann S de Bono Eric J Small Neal D Shore Karim Fizazi Thian Kheoh Jinhui Li Peter De Porre Mary B Todd Margaret K Yu Charles J Ryan

Eur Urol 2017 07 15;72(1):10-13. Epub 2017 Mar 15.

Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.eururo.2017.03.007	DOI Listing

July 2017

Convective Thermal Therapy: Durable 2-Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.

Authors:

Claus G Roehrborn Steven N Gange Marc C Gittelman Kenneth A Goldberg Kalpesh Patel Neal D Shore Richard M Levin Michael Rousseau J Randolf Beahrs Jed Kaminetsky Barrett E Cowan Christopher H Cantrill Lance A Mynderse James C Ulchaker Thayne R Larson Christopher M Dixon Kevin T McVary

J Urol 2017 06 18;197(6):1507-1516. Epub 2016 Dec 18.

Department of Urology, University of Texas Southwestern Medical Center (CGR), Dallas, Texas.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.juro.2016.12.045	DOI Listing

June 2017

Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel.

Authors:

Andrew J Armstrong Fred Saad De Phung Carl Dmuchowski Neal D Shore Karim Fizazi Mohammad Hirmand David Forer Howard I Scher Johann De Bono

Cancer 2017 Jun 7;123(12):2303-2311. Epub 2017 Feb 7.

Institute of Cancer Research, London, UK.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1002/cncr.30587	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484320	PMC

June 2017

Darolutamide (ODM-201) for the treatment of prostate cancer.

Authors:

Neal D Shore

Expert Opin Pharmacother 2017 Jun 24;18(9):945-952. Epub 2017 May 24.

a Carolina Urologic Research Center , Atlantic Urology Clinics , Myrtle Beach , SC , USA.

View Article

Download full-text PDF	Source
https://www.tandfonline.com/doi/full/10.1080/14656566.2017.1	Publisher Site
http://dx.doi.org/10.1080/14656566.2017.1329820	DOI Listing

June 2017

Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.

Can J Urol 2017 Jun;24(3):8802-8813

University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF	Source

June 2017

Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial.

Authors:

Emmanuel S Antonarakis Adam S Kibel Evan Y Yu Lawrence I Karsh Aymen Elfiky Neal D Shore Nicholas J Vogelzang John M Corman Frederick E Millard Johnathan C Maher Nancy N Chang Todd DeVries Nadeem A Sheikh Charles G Drake

Clin Cancer Res 2017 May 10;23(10):2451-2459. Epub 2016 Nov 10.

Johns Hopkins SKCCC, the Brady Urological Institute and the Bloomberg Kimmel Institute, Baltimore, Maryland.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1780	DOI Listing

May 2017

The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy.

Authors:

E David Crawford Andrew V Schally Jehonathan H Pinthus Norman L Block Ferenc G Rick Marc B Garnick Robert H Eckel Thomas E Keane Neal D Shore David N Dahdal Thomas J R Beveridge Dennis C Marshall

Urol Oncol 2017 05 18;35(5):183-191. Epub 2017 Mar 18.

Ferring Pharmaceuticals Inc., Parsippany, NJ.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.urolonc.2017.01.025	DOI Listing

May 2017

Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utility.

Authors:

E David Crawford Neal D Shore Daniel P Petrylak Celestia S Higano Charles J Ryan

Ther Adv Med Oncol 2017 May 22;9(5):319-333. Epub 2017 Mar 22.

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1177/1758834017698644	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424866	PMC

May 2017

Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.

Authors:

Johann S de Bono Matthew R Smith Fred Saad Dana E Rathkopf Peter F A Mulders Eric J Small Neal D Shore Karim Fizazi Peter De Porre Thian Kheoh Jinhui Li Mary B Todd Charles J Ryan Thomas W Flaig

Eur Urol 2017 04 9;71(4):656-664. Epub 2016 Jul 9.

University of Colorado Cancer Center, Aurora, CO, USA.

View Article

Download full-text PDF	Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838163038	Publisher Site
http://dx.doi.org/10.1016/j.eururo.2016.06.033	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609503	PMC

April 2017

Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial.

Authors:

Axel Heidenreich Simon Chowdhury Laurence Klotz David Robert Siemens Arnauld Villers Cristina Ivanescu Stefan Holmstrom Benoit Baron Fong Wang Ping Lin Neal D Shore

Eur Urol 2017 04 3;71(4):534-542. Epub 2016 Aug 3.

Carolina Urologic Research Centre, Myrtle Beach, SC, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.eururo.2016.07.027	DOI Listing

April 2017

Polymer-delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open-label studies in patients with advanced prostate cancer.

Authors:

Neal D Shore Franklin Chu Judd Moul Daniel Saltzstein Raoul Concepcion John A McLane Stuart Atkinson Alex Yang E David Crawford

BJU Int 2017 Feb 16;119(2):239-244. Epub 2016 Apr 16.

University of Colorado, Denver, Aurora, CO, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1111/bju.13482	DOI Listing

February 2017

The LUGPA Alternative Payment Model for Initial Therapy of Newly Diagnosed Patients With Organ-confined Prostate Cancer: Rationale and Development.

Authors:

Deepak A Kapoor Neal D Shore Gary M Kirsh Jonathan Henderson Todd D Cohen Kathleen Latino

Rev Urol 2017 ;19(4):235-245

Integrated Medical Professionals, PLLC Melville, NY.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3909/riu0779	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811880	PMC

January 2017

LUGPA Enhances 2017 Membership Opportunities.

Authors:

Neal D Shore

Rev Urol 2017 ;19(1):44-45

President, LUGPA; Atlantic Urology ClinicsMyrtle Beach, SC.

View Article

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434835	PMC
http://dx.doi.org/10.3909/riu0750	DOI Listing

January 2017

LUGPA news.

Authors:

Neal D Shore

Rev Urol 2017 ;19(2):119-121

President, LUGPA; Atlantic Urology ClinicsMyrtle Beach, SC.

View Article

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610362	PMC
http://dx.doi.org/10.3909/riu0761	DOI Listing

January 2017

The society of urologic oncology clinical trials consortium: A brief history and overview.

Authors:

Neal D Shore Colin Dinney Robert Uzzo

Rev Urol 2017 ;19(2):122-124

Department of Surgical Oncology, Fox Chase Cancer CenterPhiladelphia, PA.

View Article

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610363	PMC
http://dx.doi.org/10.3909/riu0760	DOI Listing

January 2017

Practice management for urology groups: LUGPA's Guidebook.

Authors:

Neal D Shore

Rev Urol 2017 ;19(3):164-168

President, LUGPA; Atlantic Urology ClinicsMyrtle Beach, SC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3909/riu0774	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737343	PMC

January 2017

Alternative payment models.

Authors:

Deepak A Kapoor Neal D Shore

Rev Urol 2017 ;19(3):198-199

President, LUGPA; Medical Director, CPI, Carolina Urologic Research Center; National Urology Research Director, 21st Century Oncology, Atlantic Urology ClinicsMyrtle Beach, SC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3909/riu193NewsinUro	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737350	PMC

January 2017

Are You Developing an ABC: Advanced Bladder Cancer Clinic?

Authors:

Neal D Shore

Rev Urol 2017 ;19(4):246-247

President, LUGPA; Atlantic Urology Clinics Myrtle Beach, SC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3909/riu0777	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811881	PMC

January 2017

Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort.

Authors:

Matthew R Smith Emmanuel S Antonarakis Charles J Ryan William R Berry Neal D Shore Glenn Liu Joshi J Alumkal Celestia S Higano Edna Chow Maneval Rajesh Bandekar Carla J de Boer Margaret K Yu Dana E Rathkopf

Eur Urol 2016 12 6;70(6):963-970. Epub 2016 May 6.

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.eururo.2016.04.023	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568792	PMC

December 2016

Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents.

Authors:

Allan Lipton Matthew R Smith Karim Fizazi Alison T Stopeck David Henry Janet E Brown Neal D Shore Fred Saad Andrew Spencer Li Zhu Douglas J Warner

Clin Cancer Res 2016 Dec 2;22(23):5713-5721. Epub 2016 May 2.

Clinical Development, Amgen Inc., Thousand Oaks, California.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-3086	DOI Listing

December 2016

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma.

Authors:

Douglas G McNeel Neil H Bander Tomasz M Beer Charles G Drake Lawrence Fong Stacey Harrelson Philip W Kantoff Ravi A Madan William K Oh David J Peace Daniel P Petrylak Hank Porterfield Oliver Sartor Neal D Shore Susan F Slovin Mark N Stein Johannes Vieweg James L Gulley

J Immunother Cancer 2016 20;4:92. Epub 2016 Dec 20.

Genitourinary Malignancies Branch, 10 Center Drive, 13N240, Bethesda, MD 20892 USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1186/s40425-016-0198-x	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170901	PMC

December 2016

An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.

Authors:

E David Crawford Matt T Rosenberg Alan W Partin Matthew R Cooperberg Michael Maccini Stacy Loeb Curtis A Pettaway Neal D Shore Paul Arangua John Hoenemeyer Mike Leveridge Michael Leapman Peter Pinto Ian M Thompson Peter Carroll James Eastham Leonard Gomella Eric A Klein

Urology 2016 Oct 19;96:116-120. Epub 2016 Jul 19.

Cleveland Clinic, Glickman Urological & Kidney Institute, Cleveland, OH.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.urology.2016.07.001	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568096	PMC

October 2016

Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer.

Authors:

Karim Fizazi Kim N Chi Johann S de Bono Leonard G Gomella Kurt Miller Dana E Rathkopf Charles J Ryan Howard I Scher Neal D Shore Peter De Porre Anil Londhe Tracy McGowan Nonko Pelhivanov Robert Charnas Mary B Todd Bruce Montgomery

Eur Urol 2016 09 7;70(3):438-44. Epub 2016 Mar 7.

University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.eururo.2016.02.035	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570464	PMC

September 2016

Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study.

Authors:

Kevin T McVary Steven N Gange Marc C Gittelman Kenneth A Goldberg Kalpesh Patel Neal D Shore Richard M Levin Michael Rousseau J Randolf Beahrs Jed Kaminetsky Barrett E Cowan Christopher H Cantrill Lance A Mynderse James C Ulchaker Thayne R Larson Christopher M Dixon Claus G Roehrborn

J Sex Med 2016 06 27;13(6):924-33. Epub 2016 Apr 27.

University of Texas Southwestern, Dallas, TX, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jsxm.2016.03.372	DOI Listing

June 2016

Response and Rebuttal to Editorial Commentary on "Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study".

Authors:

Kevin T McVary Steven N Gange Marc C Gittelman Kenneth A Goldberg Kalpesh Patel Neal D Shore Richard M Levin Michael Rousseau J Randolf Beahrs Jed Kaminetsky Barrett E Cowan Christopher H Cantrill Lance A Mynderse James C Ulchaker Thayne R Larson Christopher M Dixon Claus G Roehrborn

J Sex Med 2016 06;13(6):936-7

University of Texas Southwestern, Dallas, Texas.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jsxm.2016.05.002	DOI Listing

June 2016

LUGPA Welcomes Membership of Smaller Practices.

Authors:

Neal D Shore

Rev Urol 2015 ;17(2):86-7

LUGPA Preseident Elect; Atlantic Urology Clinics, Myrtle Beach, SC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3909/riu0672	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857900	PMC

May 2016

Extended release, 6-month formulations of leuprolide acetate for the treatment of advanced prostate cancer: achieving testosterone levels below 20 ng/dl.

Authors:

E David Crawford Judd W Moul Oliver Sartor Neal D Shore

Expert Opin Drug Metab Toxicol 2015 ;11(9):1465-74

a 1 University of Colorado Cancer Center, University of Colorado Health Sciences Center, Urologic Oncology Department , Mail Stop F710, 1665 N. Ursula Street, Rm 1004, P.O. Box 6510, Aurora, CO 80045, USA +1 720 848 0195 ; +1 720 848 0203 ;

View Article

Download full-text PDF	Source
http://www.tandfonline.com/doi/full/10.1517/17425255.2015.10	Publisher Site
http://dx.doi.org/10.1517/17425255.2015.1073711	DOI Listing

May 2016

Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Authors:

Kevin T McVary Steven N Gange Marc C Gittelman Kenneth A Goldberg Kalpesh Patel Neal D Shore Richard M Levin Michael Rousseau J Randolf Beahrs Jed Kaminetsky Barrett E Cowan Christopher H Cantrill Lance A Mynderse James C Ulchaker Thayne R Larson Christopher M Dixon Claus G Roehrborn

J Urol 2016 May 22;195(5):1529-1538. Epub 2015 Nov 22.

University of Texas Southwestern, Dallas, Texas.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.juro.2015.10.181	DOI Listing

May 2016

Highlights in Metastatic Prostate Cancer From the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Commentary.

Authors:

Neal D Shore

Clin Adv Hematol Oncol 2016 Apr;14(4 Suppl 5):17-9

Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, South Carolina.

View Article

Download full-text PDF	Source

April 2016

Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer.

Authors:

Neal D Shore Naveen Kella Brian Moran Judd Boczko Fernando J Bianco E David Crawford Thaylon Davis Kirstin M Roundy Kristen Rushton Charles Grier Rajesh Kaldate Michael K Brawer Mark L Gonzalgo

J Urol 2016 Mar 25;195(3):612-8. Epub 2015 Sep 25.

University of Miami Miller School of Medicine, Miami, Florida.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.juro.2015.09.072	DOI Listing

March 2016

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study.

Authors:

Neal D Shore Simon Chowdhury Arnauld Villers Laurence Klotz D Robert Siemens De Phung Steve van Os Nahla Hasabou Fong Wang Suman Bhattacharya Axel Heidenreich

Lancet Oncol 2016 Feb 14;17(2):153-163. Epub 2016 Jan 14.

Department of Urology, Aachen University, Aachen, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/S1470-2045(15)00518-5	DOI Listing

February 2016

When to initiate treatment with radium-223 in patients with metastatic castration-resistant prostate cancer.

Authors:

Neal D Shore

Clin Adv Hematol Oncol 2016 Jan;14(1):26-9

Atlantic Urology Clinics, Myrtle Beach, South Carolina.

View Article

Download full-text PDF	Source

January 2016

Urology Group Compensation and Ancillary Service Models in an Era of Value-based Care.

Authors:

Neal D Shore Dana Jacoby

Rev Urol 2016 ;18(3):143-150

DJI Consulting Charlotte, NC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3909/riu0726	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102930	PMC

January 2016

Prostate Cancer Academy 2016: Presentation summaries.

Authors:

E David Crawford David M Albala James S Wysocki Herbert Lepor Ashley E Ross Steven E Finkelstein Thomas Keane Stephen Freedland Richard Harris Neal D Shore Charles J Ryan

Rev Urol 2016 ;18(4):205-213

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3909/riuPCA2016	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260950	PMC

January 2016

Looking ahead to 2017.

Authors:

Neal D Shore

Rev Urol 2016 ;18(4):225

President, LUGPA; Atlantic Urology Clinics Myrtle Beach, SC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3909/riu0736	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260953	PMC

January 2016

Advanced prostate cancer in large group practices.

Authors:

David M Albala Gary M Kirsh Neal D Shore

Rev Urol 2016 ;18(4):226-230

President, LUGPA; Atlantic Urology Clinics Myrtle Beach, SC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3909/riu0737	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260954	PMC

January 2016

Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies.

Authors:

E David Crawford Celestia S Higano Neal D Shore Maha Hussain Daniel P Petrylak

J Urol 2015 Dec 18;194(6):1537-47. Epub 2015 Jul 18.

Smilow Cancer Center, Yale University, New Haven, Connecticut.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.juro.2015.06.106	DOI Listing

December 2015

Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer.

Authors:

E David Crawford Daniel P Petrylak Celestia S Higano Adam S Kibel Philip W Kantoff Eric J Small Neal D Shore Anna Ferrari

Can J Urol 2015 Dec;22(6):8048-55

University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

View Article

Download full-text PDF	Source

December 2015

Advances in the understanding of cancer immunotherapy.

Authors:

Neal D Shore

BJU Int 2015 Sep 18;116(3):321-9. Epub 2015 May 18.

Carolina Urologic Research Center/Atlantic Urology Clinics, Myrtle Beach, SC, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1111/bju.12692	DOI Listing

September 2015

A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.

Eur Urol 2015 Sep 27;68(3):464-70. Epub 2014 Oct 27.

Andover Urology, Andover, MA, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.eururo.2014.10.021	DOI Listing

September 2015

A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer.

Authors:

Eric J Small Raymond S Lance Thomas A Gardner Lawrence I Karsh Lawrence Fong Candice McCoy Todd DeVries Nadeem A Sheikh Debraj GuhaThakurta Nancy Chang Charles H Redfern Neal D Shore

Clin Cancer Res 2015 Sep 29;21(17):3862-9. Epub 2015 Apr 29.

Carolina Urologic Research Center, Myrtle Beach, South Carolina.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0079	DOI Listing

September 2015

Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America.

Authors:

Anthony M Joshua Neal D Shore Fred Saad Kim N Chi Carl A Olsson Urban Emmenegger Mark Scholz William Berry Som D Mukherjee Eric Winquist Naomi B Haas Margaret A Foley Carl Dmuchowski Frank Perabo Mohammad Hirmand Nahla Hasabou Dana Rathkopf

Prostate 2015 Jun 14;75(8):836-44. Epub 2015 Feb 14.

University Health Network/Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1002/pros.22965	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024054	PMC

June 2015

Thriving in the Independent Setting: Highlights From the 2014 LUGPA Annual Meeting.

Authors:

Neal D Shore

Rev Urol 2015 ;17(1):31-2

2014 Program Committee Chair; Atlantic Urology Clinics, Myrtle Beach, SC.

View Article

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444772	PMC

June 2015

Three year results of the prostatic urethral L.I.F.T. study.

Can J Urol 2015 Jun;22(3):7772-82

University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF	Source

June 2015

Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms.

Authors:

David I Quinn Neal D Shore Shin Egawa Winald R Gerritsen Karim Fizazi

Urol Oncol 2015 May 7;33(5):245-60. Epub 2015 Jan 7.

Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.urolonc.2014.10.009	DOI Listing

May 2015

Radium-223 dichloride for metastatic castration-resistant prostate cancer: the urologist's perspective.

Authors:

Neal D Shore

Urology 2015 Apr 11;85(4):717-24. Epub 2015 Feb 11.

Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC. Electronic address:

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.urology.2014.11.031	DOI Listing

April 2015

Combining immunotherapy and radiation for prostate cancer.

Authors:

Steven E Finkelstein Sharon Salenius Constantine A Mantz Neal D Shore Eduardo B Fernandez Jesse Shulman Francisco A Myslicki Andre M Agassi Yosef Rotterman Todd DeVries Robert Sims

Clin Genitourin Cancer 2015 Feb 28;13(1):1-9. Epub 2014 Sep 28.

Dendreon Corporation, Seattle, WA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.clgc.2014.09.001	DOI Listing

February 2015

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.

Lancet Oncol 2015 Feb 16;16(2):152-60. Epub 2015 Jan 16.

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/S1470-2045(14)71205-7	DOI Listing

February 2015

Avoiding obsolescence in advanced prostate cancer management: a guide for urologists.

Authors:

Neal D Shore Lawrence Karsh Leonard G Gomella Thomas E Keane Raoul S Concepcion E David Crawford

BJU Int 2015 Feb;115(2):188-97

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1111/bju.12665	DOI Listing

February 2015

PROSTVAC® targeted immunotherapy candidate for prostate cancer.

Authors:

Neal D Shore

Immunotherapy 2014 ;6(3):235-47

Carolina Urologic Research Center, 823 82nd Parkway, Myrtle Beach, SC 29572, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.2217/imt.13.176	DOI Listing

January 2015

Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).

Eur Urol 2014 Nov 6;66(5):815-25. Epub 2014 Mar 6.

CRCHUM, University of Montréal, Montréal, Québec, Canada.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.eururo.2014.02.056	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418928	PMC

November 2014

Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer.

Authors:

Desmond Padhi Celestia S Higano Neal D Shore Paul Sieber Erik Rasmussen Matthew R Smith

J Clin Endocrinol Metab 2014 Oct 27;99(10):E1967-75. Epub 2014 Jun 27.

Department of Medical Sciences (D.P.) and Biostatistics (E.R.), Amgen Inc (D.P.), Thousand Oaks, California 91320; Department of Medicine (C.S.H.), University of Washington, and Fred Hutchinson Cancer Research Center, Seattle, Washington 98109; Carolina Urologic Research Center, (N.D.S.), Myrtle Beach, South Carolina 29579; Urological Associates of Lancaster (P.S.), Lancaster, Pennsylvania 17604; and Massachusetts General Hospital Cancer Center (M.R.S.), Boston, Massachusetts 02114.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1210/jc.2014-1271	DOI Listing

October 2014

The Rationale for Optimal Combination Therapy With Sipuleucel-T for Patients With Castration-resistant Prostate Cancer.

Authors:

Vladimir Mouraviev Neil Mariados David Albala Raoul S Concepcion Neal D Shore Robert B Sims Mark Emberton Christopher M Pieczonka

Rev Urol 2014 ;16(3):122-30

Associated Medical Professionals of New York, Syracuse, NY.

View Article

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191632	PMC

October 2014

A urologic oncology roundtable discussion: the role of disease monitoring in treatment decision-making for patients with metastatic castration-resistant prostate cancer.

Authors:

Neal D Shore Raoul Concepcion Daniel A Barocas

Hosp Pract (1995) 2013 Oct-Nov;41(4):78-80

Carolina Urologic Research Center, Myrtle Beach, SC.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3810/hp.2013.10.1083	DOI Listing

July 2014

Long-term tolerability and efficacy of degarelix: 5-year results from a phase III extension trial with a 1-arm crossover from leuprolide to degarelix.

Authors:

E David Crawford Neal D Shore Judd W Moul Bertrand Tombal Fritz H Schröder Kurt Miller Laurent Boccon-Gibod Anders Malmberg Tine Kold Olesen Bo-Eric Persson Laurence Klotz

Urology 2014 May 22;83(5):1122-8. Epub 2014 Mar 22.

Division of Urology, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF	Source
https://linkinghub.elsevier.com/retrieve/pii/S00904295140005	Publisher Site
http://dx.doi.org/10.1016/j.urology.2014.01.013	DOI Listing

May 2014

Challenges and recommendations for early identification of metastatic disease in prostate cancer.

Authors:

E David Crawford Nelson N Stone Evan Y Yu Phillip J Koo Stephen J Freedland Susan F Slovin Leonard G Gomella E Roy Berger Thomas E Keane Paul Sieber Neal D Shore Daniel P Petrylak

Urology 2014 Mar 8;83(3):664-9. Epub 2014 Jan 8.

Yale University Cancer Center, New Haven, CT.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.urology.2013.10.026	DOI Listing

March 2014

New biomarkers in prostate cancer.

Authors:

E David Crawford Karen Ventii Neal D Shore

Oncology (Williston Park) 2014 Feb;28(2):135-42

View Article

Download full-text PDF	Source

February 2014

Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift.

Authors:

Kevin T McVary Steven N Gange Neal D Shore Damien M Bolton Barrett E Cowan B Thomas Brown Alexis E Te Peter T Chin Daniel B Rukstalis Claus G Roehrborn

J Sex Med 2014 Jan 30;11(1):279-87. Epub 2013 Sep 30.

Southern Illinois University, Springfield, IL, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1111/jsm.12333	DOI Listing

January 2014

Sequencing therapy in advanced prostate cancer: focus on sipuleucel-T.

Authors:

David I Quinn Ulka Vaishampayan Celestia S Higano Daniel W Lin Neal D Shore Tomasz M Beer

Expert Rev Anticancer Ther 2014 Jan;14(1):51-61

Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF	Source
http://search.proquest.com/openview/a3792b8afdb6152d2ddbeabd	Web Search
http://www.tandfonline.com/doi/full/10.1586/14737140.2014.84	Publisher Site
http://dx.doi.org/10.1586/14737140.2014.848065	DOI Listing

January 2014

Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer.

Authors:

Neal D Shore Paul Sieber Leanne Schimke Adam Perzin Scott Olsen

Urol Nurs 2013 Sep-Oct;33(5):236-44, 248

Watson Pharmaceuticals, Salt Lake City, UT, USA.

View Article

Download full-text PDF	Source

January 2014

The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.

Authors:

Claus G Roehrborn Steven N Gange Neal D Shore Jonathan L Giddens Damien M Bolton Barrett E Cowan B Thomas Brown Kevin T McVary Alexis E Te Shahram S Gholami Prem Rashid William G Moseley Peter T Chin William T Dowling Sheldon J Freedman Peter F Incze K Scott Coffield Fernando D Borges Daniel B Rukstalis

J Urol 2013 Dec 11;190(6):2161-7. Epub 2013 Jun 11.

University of Texas Southwestern Medical Center, Dallas, Texas; Scott and White Healthcare, Temple, Texas; Western Urological Clinic, Salt Lake City, Utah; Carolina Urological Research Center, Myrtle Beach, South Carolina; Cosmetic Surgery Hospital, Brampton, and Oakville Trafalgar Memorial Hospital, Oakville, Ontario, Canada; The Austin Hospital, Melbourne, Victoria, Australia, Urology Associates of Denver, Denver, Colorado; Atlantic Urological Associates, Daytona Beach, and Pinellas Urology, St. Petersburg, Florida; Northwestern University and Southern Illinois University, Springfield, Illinois; Weill Cornell Medical Center, New York, New York; Urology Associates of Silicon Valley, San Jose, and SD Uro-Research, San Diego, California; Port Macquarie Hospital, Port Macquarie, and Figtree Private Hospital, Figtree, New South Wales, Australia; Chesapeake Urology, Baltimore, Maryland; Freedman, MD, LTD, Las Vegas, Nevada; Geisinger Medical Center and Wake Forest University, Winston-Salem, North Carolina. Electronic address:

View Article